Markets
ACA insurance
(Sherwood News)

Selling government-sponsored insurance is looking less lucrative. It’s about to get even messier.

Cuts to Medicaid and signs that ACA enrollees are becoming costlier are weighing on some insurers. Is Centene the canary in the coal mine?

Providing healthcare on behalf of the government might be becoming less lucrative than it used to be.

On Tuesday, Centene, the largest seller of Affordable Care Act plans, tanked after it withdrew its 2025 guidance because new data showed its ACA enrollees are using their benefits significantly more than expected, which threatens to eat into profits. The government pays insurers to cover ACA enrollees based on how sick they are assumed to be.

Centene is down by about 40% Wednesday, setting it up for its worst single day since it went public in 2001.

The ACA, which passed in 2010 and took effect in 2014, gave millions of Americans access to healthcare by expanding who is eligible for Medicaid. It also created a multibillion-dollar revenue stream for insurance companies. Some struggled to offer profitable plans, in some cases even dropping off the ACA Marketplace, but the market eventually leveled and insurers like Centene wound up making up a majority of their business via the government.

The news from Centene also dragged down other insurers, including Oscar Health and Molina Healthcare. Oscar, a digital-first newcomer, does make some money from ACA plans, but not nearly as much as others. It’s also a retail favorite vulnerable to speculation.

Molina, on the other hand, is in a similar boat as Centene. Nearly all of its revenue comes from selling Medicare and Medicaid plans. The company fell 20% on Wednesday.

But sicker ACA enrollees may be just the start of their problems.

President Trump and his supporters in Congress have made it their mission to cut government spending on social programs, and Medicaid and Medicare are at the top of their list. Republicans are pushing a bill that would result in the largest cut to Medicaid in history, threatening to shrink a key revenue stream.

UnitedHealthcare, the insurance arm of the conglomerate United Health Group, is also down for the year, but not quite for the same reasons.

UNH, the largest health insurer in the country, gets a larger sum of its revenue from Medicare Advantage. The program allows American seniors to get their government-funded healthcare through a private insurer. UNH said in its most recent earnings report that its Medicare Advantage costs were higher than expected.

Higher costs are also not the company’s only issue. The head of its insurance arm, Brian Thompson, was killed in Manhattan in December in a high-profile shooting, with alleged gunman Luigi Mangione having expressed frustration with healthcare companies. UnitedHealth ousted its CEO in May amid increased government scrutiny over potential fraud in its Medicare Advantage program as well as antitrust probe. A whistleblower report by The Guardian set it back another notch.

UNH and its peers may not have an easy time winning over lawmakers and regulators, even if cutting their revenue streams means Americans, especially the poor and vulnerable, will die.

More Markets

See all Markets
markets

Report: US senators plan to introduce bill blocking Nvidia from selling advanced chips to China for 30 months

US senators are on the verge of introducing a bill that would block Nvidia from selling its H200 or Blackwell chips to China for 30 months, the Financial Times reports. The H200 is Nvidia’s best chip from the Hopper generation, while the Blackwell line is its current flagship offering.

Shares of the chip designer are little changed in the wake of this report, still up more than 1% on the session. The reaction makes sense, seeing as previous positive indications on Nvidia’s ability to sell advanced chips to China failed to inspire much positive momentum in its shares.

The stock got a short-lived jolt higher (that didn’t last the day!) on November 21 after Bloomberg reported that the Trump administration had discussed the possibility of selling its H200 chips to China.

Nvidia has effectively been shut out of China’s AI market in 2025. First, export restrictions meant it could no longer sell the H20, a nerfed version of its Hopper chip, to the world’s second-largest economy. After that export ban was lifted, demand from China “never materialized,” per Nvidia CFO Colette Kress. Reports indicate that China banned its leading technology giants from purchasing these semiconductors, instead pushing them toward domestic alternatives.

President Donald Trump had mused about allowing Nvidia to sell Blackwell chips to China prior to his meeting with Chinese President Xi in late October, but failed to do so. The two leaders did not discuss the topic at that time.

Per the FT, this upcoming bill would be a bipartisan effort, being cosponsored by the leading Republican and Democrat members of the Senate Foreign Relations East Asia subcommittee.

markets

AI energy plays soar on an explosion of call buying

Like their quantum computing counterparts, AI-linked energy plays are benefiting from an explosion of bullish options activity on Thursday.

  • Oklo is up double digits with call volumes above 106,000 as of 2:46 p.m. ET, more than double its 20-day average for a full session, with a put/call ratio of about 0.6. Call options with a strike price of $110 that expire this Friday (which are now in-the-money thanks to today’s surge) are seeing the most activity.

  • Nuscale, another nuclear energy play, has seen nearly 140,000 call options change hands versus a 20-day average of 51,073.

  • And fuel cell company Bloom Energy has traded nearly 80,000 calls, roughly twice its 20-day average, with a put/call ratio of about 0.3.

During his appearance on Joe Rogan’s podcast released on Wednesday, Nvidia CEO Jensen Huang talked up the potential for nuclear energy, saying, “In the next six to seven years I think you are going to see a whole bunch of small nuclear reactors.”

This adds to the evidence that the speculative bid is back in a big way after smaller stocks tied to the AI boom and quantum computing cratered from mid-October through most of November as credit risk began to seep into the AI trade.

Old electronic items tossed on ground for disposal, Hudson

Technology giants don’t look like they used to, as the asset-light era fades

Oracle and Meta are now some of the most capital-intensive businesses in the S&P 500, spending more than energy giants. I guess data really is the new oil?

markets

Space stocks rip amid speculation on Altman joining race

Space stocks AST SpaceMobile, Planet Labs, and Rocket Lab all soared Thursday amid a recovery in the high-beta momentum class of shares coveted by some retail traders.

(High-beta momo stocks are basically shares that have been on a winning streak for a while, and tend to go up a lot more than the overall market on positive days. Goldman Sachs includes all three of the aforementioned space stocks in its themed basket of such shares.)

There’s little other fundamental news out there on the companies themselves.

But a Wall Street Journal report that OpenAI impresario Sam Altman has been toying with the idea of entering the space industry, potentially standing up a rival to Tesla CEO Elon Musk’s Starlink satellite service, may also be contributing.

As we’ve mentioned elsewhere, sometimes these stocks seem to trade on a what’s-bad-for-the-Musk-empire-is-good-for-us-and-vice-versa vibe.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.